Rivastigmine Transdermal Patches Market Insights Video
According to Cognitive Market Research, the global rivastigmine transdermal patches market size will be USD 7981.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 3192.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2394.36 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1835.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 399.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 159.62 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
The 9.5mg/24hr is the fastest growing segment of the rivastigmine transdermal patches industry
